| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.34 | 0.1 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.33 | 0.1 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.28 | 0.7 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.24 | 0.3 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.23 | 8e-05 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.2 | 0.4 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.02 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.17 | 0.4 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.3 |